Luis Monge Selected Research

Meclofenamic Acid (Meclofenamate)

2/2008	Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion.
1/2006	Vasoconstrictor prostanoids may be involved in reduced coronary reactive hyperemia after ischemia-reperfusion in anesthetized goats.
6/2005	Coronary effects of endothelin-1 and vasopressin during acute hypotension in anesthetized goats.
7/2004	Vasopressin effects on the coronary circulation after a short ischemia in anesthetized goats: role of nitric oxide and prostanoids.
5/2004	Coronary action of endothelin-1 and vasopressin during acute hypertension in anesthetized goats. Role of nitric oxide and prostanoids.
7/2003	Coronary effects of vasopressin during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids.
12/2002	Coronary reactivity to endothelin-1 during partial ischemia and reperfusion in anesthetized goats. Role of nitric oxide and prostanoids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis Monge Research Topics

Disease

18	Ischemia 10/2015 - 12/2002
4	Coronary Occlusion 05/2006 - 12/2002
3	Hypertension (High Blood Pressure) 04/2020 - 08/2002
3	Diabetes Mellitus 06/2003 - 02/2003
2	Hyperemia 11/2006 - 01/2006
1	Ischemic Stroke 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Infarction (Infarctions) 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Stroke (Strokes) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2020
1	Insulin Resistance 04/2020
1	Reperfusion Injury 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Neoplasms (Cancer) 01/2013
1	Vascular Diseases (Vascular Disease) 05/2009
1	Fibrosis (Cirrhosis) 10/2007
1	Hypotension (Low Blood Pressure) 06/2005
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2002
1	Pathologic Constriction (Stenosis) 08/2002

Drug/Important Bio-Agent (IBA)

13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 12/2002
13	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2014 - 08/2002
11	Endothelin-1 (Endothelin 1)IBA 06/2011 - 08/2002
9	ProstaglandinsIBA 11/2006 - 12/2002
7	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 08/2002
7	Vasoconstrictor AgentsIBA 07/2010 - 12/2002
7	Meclofenamic Acid (Meclofenamate)FDA LinkGeneric 02/2008 - 12/2002
6	Vasodilator Agents (Vasodilators)IBA 01/2006 - 12/2002
5	Peptides (Polypeptides)IBA 05/2009 - 06/2003
5	Vasopressins (Vasopressin)IBA 06/2005 - 06/2003
4	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2006 - 12/2002
4	Arginine (L-Arginine)FDA Link 06/2005 - 12/2002
3	Cibacron Blue F 3GAIBA 01/2014 - 06/2011
3	Purinergic P2Y ReceptorsIBA 01/2014 - 06/2011
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 07/2010 - 11/2005
3	Endothelins (Endothelin)IBA 02/2008 - 11/2005
3	Cyclooxygenase InhibitorsIBA 02/2008 - 05/2004
3	UrocortinsIBA 06/2005 - 06/2003
2	Angiotensin IIIBA 04/2020 - 05/2009
2	Purinergic Receptors (Receptors, Purine)IBA 10/2015 - 01/2014
2	Glyburide (Glibenclamide)FDA LinkGeneric 08/2012 - 06/2011
2	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 08/2012 - 02/2005
2	cyclo(Trp-Asp-Pro-Val-Leu)IBA 02/2008 - 05/2006
2	BQ 788IBA 02/2008 - 05/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2005 - 01/2004
2	arginine methyl esterIBA 02/2005 - 07/2004
2	Arginine Vasopressin (Argipressin)IBA 07/2004 - 07/2003
2	Streptozocin (Streptozotocin)FDA Link 06/2003 - 02/2003
1	InflammasomesIBA 01/2022
1	triphenyltetrazoliumIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	Insulin (Novolin)FDA Link 04/2020
1	oxidized low density lipoproteinIBA 04/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2020
1	LDL CholesterolIBA 04/2020
1	CholesterolIBA 04/2020
1	Blood Glucose (Blood Sugar)IBA 04/2020
1	AntioxidantsIBA 04/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	Messenger RNA (mRNA)IBA 04/2020
1	locust bean gum (carob)FDA Link 04/2020
1	brilliant blue (brilliant blue FCF)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA 01/2014
1	Purinergic P2X ReceptorsIBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	diadenosine triphosphate (ApppA)IBA 08/2012
1	Adenosine Triphosphate (ATP)IBA 08/2012
1	N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphateIBA 08/2012
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 08/2012
1	Uridine Triphosphate (UTP)IBA 06/2011
1	WortmanninIBA 06/2011
1	bisindolylmaleimide IIBA 06/2011
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 06/2011
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 06/2011
1	diadenosine tetraphosphateIBA 06/2011
1	IsatinIBA 06/2011
1	KATP ChannelsIBA 06/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2010
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2010
1	TyramineIBA 07/2010
1	galantide (M 15)IBA 02/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2007
1	Adenosine Diphosphate (ADP)IBA 11/2006
1	endothelium-dependent hyperpolarization factor (EDHF)IBA 11/2006
1	Thromboxane A2 (A2, Thromboxane)IBA 02/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2004
1	Corticotropin-Releasing HormoneIBA 06/2003
1	Thromboxane Receptors (Thromboxane Receptor)IBA 02/2003

Therapy/Procedure

1	Baths 02/2008
1	Liver Transplantation 10/2007